Acceder Registro /

ELENA MARTÍNEZ BALSALOBRE

Buscador

Bernabé-García M, Martínez-Balsalobre E, García-Moreno D, García-Castillo J, Revilla-Nuin B, Blanco-Alcaina E, Mulero V, Alcaraz-Pérez F, Cayuela ML. Telomerase reverse transcriptase activates transcription of miR500A to inhibit Hedgehog signalling and promote cell invasiveness. Mol Oncol. 2021 Jul;15(7):1818-1834. doi: 10.1002/1878-0261.12943. Epub 2021 May 2. PubMed PMID: 33713376; PubMed Central PMCID: PMC8253104.
AÑO: 2021; IF: 6.6
García-Castillo J, Alcaraz-Pérez F, Martínez-Balsalobre E, García-Moreno D, Rossmann MP, Fernández-Lajarín M, Bernabé-García M, Pérez-Oliva AB, Rodríguez-Cortez VC, Bueno C, Adatto I, Agarwal S, Menéndez P, Zon LI, Mulero V, Cayuela ML. Telomerase RNA recruits RNA polymerase II to target gene promoters to enhance myelopoiesis. Proc Natl Acad Sci U S A. 2021 Aug 10;118(32). pii: e2015528118. doi: 10.1073/pnas.2015528118. PubMed PMID: 34353901; PubMed Central PMCID: PMC8364177.
AÑO: 2021; IF: 11.1
Autores:
Lee L, Perez Oliva AB, Martinez-Balsalobre E, Churikov D, Peter J, Rahmouni D, Audoly G, Azzoni V, Audebert S, Camoin L, Mulero V, Cayuela ML, Kulathu Y, Geli V, Lachaud C. UFMylation of MRE11 is essential for telomere length maintenance and hematopoietic stem cell survival. Sci Adv. 2021 Sep 24;7(39):eabc7371. doi: 10.1126/sciadv.abc7371. Epub 2021 Sep 24. PubMed PMID: 34559557; PubMed Central PMCID: PMC8462904.
AÑO: 2021; IF: 14.957
Autores:
Peris I, Romero-Murillo S, Martinez-Balsalobre E, Farrington CC, Arriazu E, Marcotegui N, Jimenez-Munoz M, Alburquerque-Prieto C, Torres-Lopez A, Fresquet VJ, Martinez-Climent JA, Mateos MC, Cayuela ML, Narla G, Odero MD, Vicente C. Activation of the PP2A-B56alpha heterocomplex synergizes with venetoclax therapies in AML through BCL2 and MCL1 modulation. Blood. 2022 Dec 1:blood.2022016466. doi: 10.1182/blood.2022016466. Online ahead of print. PubMed PMID: 36455198.
AÑO: 2022; IF: 20.3
Autores:
Martinez-Balsalobre E, Guervilly JH, van Asbeck-van der Wijst J, Perez-Oliva AB, Lachaud C. Beyond current treatment of Fanconi Anemia: What do advances in cell and gene-based approaches offer? Blood Rev. 2023 Jul;60:101094. doi: 10.1016/j.blre.2023.101094. Epub 2023 Apr 28. PubMed PMID: 37142543.
AÑO: 2023; IF: 7.4
Autores:
  • ELENA MARTÍNEZ BALSALOBRE
  • ANA BELÉN PÉREZ OLIVA

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R